Singapore markets open in 4 hours 12 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,048.42 -23.21 (-0.46%) Dow
38,085.80 -375.12 (-0.98%) Nasdaq
15,611.76 -100.99 (-0.64%) Bitcoin USD
64,793.59 +737.68 (+1.15%) CMC Crypto 200
1,397.32 +14.74 (+1.07%)
Karyopharm Therapeutics Inc. (KPTI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 126.95M |
| Enterprise value | 112.52M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.85 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 0.77 |
| Enterprise value/EBITDA | -0.95 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.06 |
| 52-week change 3 | -68.86% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 3.8650 |
| 52-week low 3 | 0.6170 |
| 50-day moving average 3 | 1.3254 |
| 200-day moving average 3 | 1.1845 |
Share statistics
| Avg vol (3-month) 3 | 1.81M |
| Avg vol (10-day) 3 | 1.36M |
| Shares outstanding 5 | 116.47M |
| Implied shares outstanding 6 | 115.07M |
| Float 8 | 105.29M |
| % held by insiders 1 | 4.41% |
| % held by institutions 1 | 67.44% |
| Shares short (15 Apr 2024) 4 | 23.56M |
| Short ratio (15 Apr 2024) 4 | 23.27 |
| Short % of float (15 Apr 2024) 4 | 20.66% |
| Short % of shares outstanding (15 Apr 2024) 4 | 20.23% |
| Shares short (prior month 15 Mar 2024) 4 | 23.13M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -97.99% |
| Operating margin (ttm) | -112.03% |
Management effectiveness
| Return on assets (ttm) | -27.05% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 146.03M |
| Revenue per share (ttm) | 1.28 |
| Quarterly revenue growth (yoy) | 0.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -129.01M |
| Net income avi to common (ttm) | -143.1M |
| Diluted EPS (ttm) | -1.2500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 191.44M |
| Total cash per share (mrq) | 1.66 |
| Total debt (mrq) | 309.5M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.37 |
| Book value per share (mrq) | -1.18 |
Cash flow statement
| Operating cash flow (ttm) | -92.72M |
| Levered free cash flow (ttm) | -39.95M |
© 2024 Yahoo. All rights reserved.